Amdocs (NASDAQ:DOX) issued its quarterly earnings results on Thursday. The technology company reported $0.90 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.92 by ($0.02), Morningstar.com reports. Amdocs had a return on equity of 15.00% and a net margin of 10.56%. The company had revenue of $1 billion for the quarter, compared to analysts’ expectations of $1 billion. During the same quarter last year, the company earned $0.94 EPS. Amdocs’s revenue for the quarter was up 2.3% compared to the same quarter last year.

DOX opened at $66.79 on Friday. Amdocs has a one year low of $60.50 and a one year high of $71.72. The stock has a market capitalization of $9.23 billion, a PE ratio of 17.86, a price-to-earnings-growth ratio of 1.87 and a beta of 0.52.

Several institutional investors and hedge funds have recently added to or reduced their stakes in DOX. CENTRAL TRUST Co boosted its position in shares of Amdocs by 58.5% in the 2nd quarter. CENTRAL TRUST Co now owns 8,288 shares of the technology company’s stock valued at $549,000 after purchasing an additional 3,060 shares during the period. State of Alaska Department of Revenue boosted its position in shares of Amdocs by 21.5% in the 2nd quarter. State of Alaska Department of Revenue now owns 42,332 shares of the technology company’s stock valued at $2,800,000 after purchasing an additional 7,490 shares during the period. Bank of Montreal Can boosted its position in shares of Amdocs by 5.9% in the 2nd quarter. Bank of Montreal Can now owns 966,192 shares of the technology company’s stock valued at $63,953,000 after purchasing an additional 53,965 shares during the period. Amalgamated Bank boosted its position in shares of Amdocs by 5.0% in the 2nd quarter. Amalgamated Bank now owns 16,155 shares of the technology company’s stock valued at $1,069,000 after purchasing an additional 762 shares during the period. Finally, Nisa Investment Advisors LLC boosted its position in shares of Amdocs by 3.4% in the 2nd quarter. Nisa Investment Advisors LLC now owns 60,080 shares of the technology company’s stock valued at $3,977,000 after purchasing an additional 2,000 shares during the period. Institutional investors and hedge funds own 91.13% of the company’s stock.

Several equities research analysts have weighed in on DOX shares. Zacks Investment Research upgraded Amdocs from a “sell” rating to a “hold” rating in a report on Thursday, September 6th. BidaskClub upgraded Amdocs from a “strong sell” rating to a “sell” rating in a report on Friday, September 14th. Barclays set a $73.00 price target on Amdocs and gave the stock a “hold” rating in a report on Wednesday, August 1st. Robert W. Baird reiterated a “hold” rating and issued a $72.00 price objective on shares of Amdocs in a report on Thursday, August 2nd. Finally, Citigroup dropped their price objective on Amdocs from $79.00 to $77.00 and set a “buy” rating on the stock in a report on Thursday, August 2nd. One research analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $72.60.

COPYRIGHT VIOLATION WARNING: This news story was first posted by Daily Political and is the property of of Daily Political. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The legal version of this news story can be viewed at https://www.dailypolitical.com/2018/11/10/amdocs-dox-announces-quarterly-earnings-results.html.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services solutions to the communications, entertainment, pay TV, and media industry service providers worldwide. The company offers customer experience and monetization solutions that allow its customers to contextual and personalize interactions.

Further Reading: What is a Call Option?

Earnings History for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.